Iain Ross - 02 Jan 2025 Form 3 Insider Report for Silence Therapeutics plc (SLN)

Role
Director
Signature
/s/ Rhonda Hellums, Attorney-in-Fact
Issuer symbol
SLN
Transactions as of
02 Jan 2025
Net transactions value
$0
Form type
3
Filing time
02 Jan 2025, 16:38:35 UTC
Next filing
22 Dec 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SLN Ordinary Shares 39,942 02 Jan 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SLN Share Option (Right to Buy) 02 Jan 2025 Ordinary Shares 250,000 $0.8000 Direct F1
holding SLN Share Option (Right to Buy) 02 Jan 2025 Ordinary Shares 250,000 $2.53 Direct F1
holding SLN Share Option (Right to Buy) 02 Jan 2025 Ordinary Shares 150,000 $0.0700 Direct F1
holding SLN Share Option (Right to Buy) 02 Jan 2025 Ordinary Shares 350,000 $5.87 Direct F1
holding SLN Share Option (Right to Buy) 02 Jan 2025 Ordinary Shares 90,000 $7.87 Direct F2
holding SLN Share Option (Right to Buy) 02 Jan 2025 Ordinary Shares 90,000 $5.13 Direct F3
holding SLN Share Option (Right to Buy) 02 Jan 2025 Ordinary Shares 90,000 $5.90 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately exercisable.
F2 This option vested or shall vest in equal monthly installments over a three-year period measured from one month following January 6, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date.
F3 This option vested or shall vest in equal monthly installments over a three-year period measured from one month following September 14, 2023, subject to the Reporting Person's continuous service as of the applicable vesting date.
F4 This option vested or shall vest in equal monthly installments over a three-year period measured from one month following January 4, 2024, subject to the Reporting Person's continuous service as of the applicable vesting date.